Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Callegaro

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
CNS & Neurological Disorders Drug Targets|August 18, 2023
Mycotoxins and Amyotrophic Lateral Sclerosis: Food Exposure, Nutritional Implications and Dietary SolutionsUmberto Manera, Enrico Matteoni, Antonio Canosa, et al.
Journal of Neurology|October 25, 2023
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosisBarbara Iazzolino, Maurizio Grassano, Cristina Moglia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 11, 2022
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patientsRosario Vasta, Stefano Callegaro, Maurizio Grassano, et al.
European Journal of Neurology|December 6, 2024
Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onsetUmberto Manera, Stefano Callegaro, Antonio Canosa, et al.
Journal of Neurology|July 21, 2025
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohortFrancesca Palumbo, Barbara Iazzolino, Cristina Moglia, et al.
Annals of Clinical and Translational Neurology|October 14, 2025
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare DiseaseRosario Vasta, Stefano Callegaro, Antonio Canosa, et al.
Annals of Neurology|April 3, 2024
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional AnalysisMaurizio Grassano, Cristina Moglia, Francesca Palumbo, et al.
Brain : a Journal of Neurology|May 8, 2026
King's stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivityFrancesca Di Pede, Sara Cabras, Umberto Manera, et al.
Neurology|March 24, 2025
Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995-2018): Results From the Piemonte and Valle d'Aosta RegistryRosario Vasta, Filippo De Mattei, Salvatore Tafaro, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
CNS & Neurological Disorders Drug Targets|August 18, 2023
Mycotoxins and Amyotrophic Lateral Sclerosis: Food Exposure, Nutritional Implications and Dietary SolutionsUmberto Manera, Enrico Matteoni, Antonio Canosa, et al.
Journal of Neurology|October 25, 2023
High serum uric acid levels are protective against cognitive impairment in amyotrophic lateral sclerosisBarbara Iazzolino, Maurizio Grassano, Cristina Moglia, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 5, 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 11, 2022
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patientsRosario Vasta, Stefano Callegaro, Maurizio Grassano, et al.
European Journal of Neurology|December 6, 2024
Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onsetUmberto Manera, Stefano Callegaro, Antonio Canosa, et al.
Journal of Neurology|July 21, 2025
Exploring the phenotypic fingerprints of ANXA11 variants in ALS: a population-based study in an European cohortFrancesca Palumbo, Barbara Iazzolino, Cristina Moglia, et al.
Annals of Clinical and Translational Neurology|October 14, 2025
Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare DiseaseRosario Vasta, Stefano Callegaro, Antonio Canosa, et al.
Annals of Neurology|April 3, 2024
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional AnalysisMaurizio Grassano, Cristina Moglia, Francesca Palumbo, et al.
Brain : a Journal of Neurology|May 8, 2026
King's stages of amyotrophic lateral sclerosis: an 18F-FDG-PET study of brain connectivityFrancesca Di Pede, Sara Cabras, Umberto Manera, et al.
Neurology|March 24, 2025
Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995-2018): Results From the Piemonte and Valle d'Aosta RegistryRosario Vasta, Filippo De Mattei, Salvatore Tafaro, et al.
Pageof 2